Enzyte Maker Sued Over Ad Claims

Driving relevance means driving growth. Join global brands and industry thought leaders at Brandweek, Sept. 11–14 in Miami, for actionable takeaways to better your marketing. 50% off passes ends April 10.

Berkeley Premium Neutraceuticals in Cincinnati has been hit with two class-action lawsuits over its Enzyte “all-natural male enhancement” product. Both allege there is no evidence to support Enzyte’s advertised claim that it increases penis size, and both seek cash back for thousands of customers.

The suits, filed in Ohio and California in March, are the latest in a line of troubles for Berkeley. Until now, the company has promoted Enzyte without any peer-reviewed scientific evidence, a rep confirmed.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in